567 related articles for article (PubMed ID: 16625861)
1. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
[TBL] [Abstract][Full Text] [Related]
3. Cortistatin-8, a synthetic cortistatin-derived ghrelin receptor ligand, does not modify the endocrine responses to acylated ghrelin or hexarelin in humans.
Prodam F; Benso A; Gramaglia E; Lucatello B; Riganti F; van der Lely AJ; Deghenghi R; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2008 Feb; 42(1):89-93. PubMed ID: 18061663
[TBL] [Abstract][Full Text] [Related]
4. Brain-gut communication: cortistatin, somatostatin and ghrelin.
Broglio F; Papotti M; Muccioli G; Ghigo E
Trends Endocrinol Metab; 2007 Aug; 18(6):246-51. PubMed ID: 17632010
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor.
Ghigo E; Broglio F; Arvat E; Maccario M; Papotti M; Muccioli G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):1-17. PubMed ID: 15638864
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands.
Bresciani E; Tamiazzo L; Torsello A; Bulgarelli I; Rapetti D; Caporali S; Perrissoud D; Moulin A; Fehrentz JA; Martinez J; Locatelli V
Eat Weight Disord; 2008 Sep; 13(3):e67-74. PubMed ID: 19011367
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin: endocrine, metabolic and cardiovascular actions.
Broglio F; Prodam F; Me E; Riganti F; Lucatello B; Granata R; Benso A; Muccioli G; Ghigo E
J Endocrinol Invest; 2005; 28(5 Suppl):23-5. PubMed ID: 16114271
[TBL] [Abstract][Full Text] [Related]
10. The role of cortistatin in the human immune system.
van Hagen PM; Dalm VA; Staal F; Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):141-7. PubMed ID: 18450367
[TBL] [Abstract][Full Text] [Related]
11. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences.
Benso A; Broglio F; Marafetti L; Lucatello B; Seardo MA; Granata R; Martina V; Papotti M; Muccioli G; Ghigo E
Semin Vasc Med; 2004 May; 4(2):107-14. PubMed ID: 15478030
[TBL] [Abstract][Full Text] [Related]
13. Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead.
Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Vázquez-Martínez R; Malagón MM; Castaño JP
Mol Cell Endocrinol; 2008 May; 286(1-2):128-34. PubMed ID: 18215456
[TBL] [Abstract][Full Text] [Related]
14. GH-releasing peptides and bone.
Cocchi D; Maccarinelli G; Sibilia V; Tulipano G; Torsello A; Pazzaglia UE; Giustina A; Netti C
J Endocrinol Invest; 2005; 28(8 Suppl):11-4. PubMed ID: 16323823
[TBL] [Abstract][Full Text] [Related]
15. Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.
Gottero C; Prodam F; Destefanis S; Benso A; Gauna C; Me E; Filtri L; Riganti F; Van Der Lely AJ; Ghigo E; Broglio F
Growth Horm IGF Res; 2004 Oct; 14(5):382-7. PubMed ID: 15336231
[TBL] [Abstract][Full Text] [Related]
16. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
Cassoni P; Allia E; Marrocco T; Ghè C; Ghigo E; Muccioli G; Papotti M
J Endocrinol Invest; 2006 Oct; 29(9):781-90. PubMed ID: 17114908
[TBL] [Abstract][Full Text] [Related]
18. Cortistatin - a new neuroendocrine hormone?
Rubinfeld H; Shimon I
Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):106-10. PubMed ID: 17342027
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
Broglio F; Koetsveld Pv Pv; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Gauna C; Hofland L; Deghenghi R; Arvat E; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4829-32. PubMed ID: 12364482
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin, cortistatin and their receptors in tumours.
Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
